Prot #17938: GALILEO: Global Multicenter, Open-Label, Randomized, Event-Driven, Active-Controlled Study Comparing a RivAroxaban-Based Antithrombotic Strategy to an AntipLatelet-Based Strategy After Transcatheter AortIc VaLve Replacement (TAVR) to Optimize

Project: Research project

Project Details

StatusFinished
Effective start/end date4/11/16 → 4/11/19

Funding

  • Icahn School of Medicine at Mount Sinai (Prot#17938 // Prot#17938)
  • Bayer HealthCare Pharmaceuticals, Inc. (Prot#17938 // Prot#17938)